An unusual cutaneous-polyposis syndrome stabilized with acitretin

L Schmulewitz; N Attard; L Fearfield; D Westaby; P Prasad; H J W Thomas; C B Bunker

doi:10.1111/j.1365-2133.2008.08646.x

An unusual cutaneous-polyposis syndrome stabilized with acitretin

Br J Dermatol. 2008 Jul;159(1):228-30. doi: 10.1111/j.1365-2133.2008.08646.x. Epub 2008 Jul 1.

Authors

L Schmulewitz¹, N Attard, L Fearfield, D Westaby, P Prasad, H J W Thomas, C B Bunker

Affiliation

¹ Department of Dermatology, Chelsea and Westminster Hospital NHS Foundation Trust, London SW10 9NH, UK.

PMID: 18503591
DOI: 10.1111/j.1365-2133.2008.08646.x

Abstract

We present a patient with an unusual enterocutaneous syndrome. Long-term, low-dose acitretin treatment has stabilized the development of gastrointestinal lesions while synchronously reducing cutaneous morbidity.

Publication types

Case Reports

MeSH terms

Acitretin / administration & dosage*
Adenomatous Polyps / diagnosis
Adenomatous Polyps / drug therapy*
Carcinoma, Squamous Cell / diagnosis
Carcinoma, Squamous Cell / drug therapy*
Female
Genes, Neoplasm / genetics
Humans
Intestinal Polyposis / diagnosis
Intestinal Polyposis / drug therapy*
Keratolytic Agents / administration & dosage*
Liver / enzymology
Middle Aged
Skin Neoplasms / diagnosis
Skin Neoplasms / drug therapy*
Syndrome
Treatment Outcome

Substances

Keratolytic Agents
Acitretin